Greenleaf Trust’s Innospec IOSP Stock Holding History

Greenleaf Trust’s Portfolio IOSP Stock Details IOSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,722	Closed	-$279K	–	784
2023 Q1	$279K	Buy	2,722 +105	+4%	+$11.3K	﹤0.01%	624
2022 Q4	$269K	Buy	+2,617	New	+$266K	﹤0.01%	619

Other funds holding IOSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Greenleaf Trust's IOSP Position: Q2 2023 in Review

Greenleaf Trust sold out of Innospec (IOSP) in Q2 2023, closing a stake of 2,722 shares — an estimated $279K sold.

Greenleaf Trust first reported a position in IOSP in Q4 2022 and held it in 2 quarters. The position peaked at $279K in Q1 2023. 204 funds tracked by Wall St. Rank hold IOSP as of Q2 2023.

Greenleaf Trust reported no remaining Innospec position as of Q2 2023 after selling out during the quarter.
Greenleaf Trust sold 2,722 Innospec shares in Q2 2023, an estimated $279K.
Greenleaf Trust first reported a position in Innospec in Q4 2022 and held it in 2 quarters.
Greenleaf Trust's Innospec position peaked at $279K in Q1 2023.
204 funds tracked by Wall St. Rank held Innospec as of Q2 2023.

Based on Greenleaf Trust's 13F filing for Q2 2023, filed 9 Aug 2023.